Literature DB >> 10516011

Phosphorylation of simian cytomegalovirus assembly protein precursor (pAPNG.5) and proteinase precursor (pAPNG1): multiple attachment sites identified, including two adjacent serines in a casein kinase II consensus sequence.

S M Plafker1, A S Woods, W Gibson.   

Abstract

The assembly protein precursor (pAP) of cytomegalovirus (CMV), and its homologs in other herpesviruses, functions at several key steps during the process of capsid formation. This protein, and the genetically related maturational proteinase, is distinguished from the other capsid proteins by posttranslational modifications, including phosphorylation. The objective of this study was to identify sites at which pAP is phosphorylated so that the functional significance of this modification and the enzyme(s) responsible for it can be determined. In the work reported here, we used peptide mapping, mass spectrometry, and site-directed mutagenesis to identify two sets of pAP phosphorylation sites. One is a casein kinase II (CKII) consensus sequence that contains two adjacent serines, both of which are phosphorylated. The other site(s) is in a different domain of the protein, is phosphorylated less frequently than the CKII site, does not require preceding CKII-site phosphorylation, and causes an electrophoretic mobility shift when phosphorylated. Transfection/expression assays for proteolytic activity showed no gross effect of CKII-site phosphorylation on the enzymatic activity of the proteinase or on the substrate behavior of pAP. Evidence is presented that both the CKII sites and the secondary sites are phosphorylated in virus-infected cells and plasmid-transfected cells, indicating that these modifications can be made by a cellular enzyme(s). Apparent compartmental differences in phosphorylation of the CKII-site (cytoplasmic) and secondary-site (nuclear) serines suggest the involvement of more that one enzyme in these modifications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516011      PMCID: PMC112937     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases.

Authors:  P J Kennelly; E G Krebs
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

2.  The herpes simplex virus 1 gene encoding a protease also contains within its coding domain the gene encoding the more abundant substrate.

Authors:  F Y Liu; B Roizman
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Processing of the herpes simplex virus assembly protein ICP35 near its carboxy terminal end requires the product of the whole of the UL26 reading frame.

Authors:  V G Preston; F J Rixon; I M McDougall; M McGregor; M F al Kobaisi
Journal:  Virology       Date:  1992-01       Impact factor: 3.616

4.  A herpesvirus maturational proteinase, assemblin: identification of its gene, putative active site domain, and cleavage site.

Authors:  A R Welch; A S Woods; L M McNally; R J Cotter; W Gibson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

5.  Protein (serine and threonine) phosphate phosphatases.

Authors:  S Shenolikar; T S Ingebritsen
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

6.  Characterization of post-translational products of herpes simplex virus gene 35 proteins binding to the surfaces of full capsids but not empty capsids.

Authors:  D K Braun; B Roizman; L Pereira
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

7.  Serine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation.

Authors:  J L Kolman; N Taylor; D R Marshak; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  Herpesvirus proteinase: site-directed mutagenesis used to study maturational, release, and inactivation cleavage sites of precursor and to identify a possible catalytic site serine and histidine.

Authors:  A R Welch; L M McNally; M R Hall; W Gibson
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

9.  Protein counterparts of human and simian cytomegaloviruses.

Authors:  W Gibson
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

10.  Immunocytochemical localization of casein kinase II during interphase and mitosis.

Authors:  I J Yu; D L Spector; Y S Bae; D R Marshak
Journal:  J Cell Biol       Date:  1991-09       Impact factor: 10.539

View more
  4 in total

1.  Angiotensin II-acetylcholine noncovalent complexes analyzed with MALDI-ion mobility-TOF MS.

Authors:  Amina S Woods; Katrin Fuhrer; Marc Gonin; Tom Egan; Michael Ugarov; Kent J Gillig; J Albert Schultz
Journal:  J Biomol Tech       Date:  2003-03

2.  The amino-conserved domain of human cytomegalovirus UL80a proteins is required for key interactions during early stages of capsid formation and virus production.

Authors:  Amy N Loveland; Nang L Nguyen; Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

3.  Assembly protein precursor (pUL80.5 homolog) of simian cytomegalovirus is phosphorylated at a glycogen synthase kinase 3 site and its downstream "priming" site: phosphorylation affects interactions of protein with itself and with major capsid protein.

Authors:  Rebecca J Casaday; Justin R Bailey; Suzanne R Kalb; Edward J Brignole; Amy N Loveland; Robert J Cotter; Wade Gibson
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  Ammonium sulfate and MALDI in-source decay: a winning combination for sequencing peptides.

Authors:  Alice Delvolve; Amina S Woods
Journal:  Anal Chem       Date:  2009-12-01       Impact factor: 6.986

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.